How did ARGX's revenue and expenses trend in Q4 2024 compared to previous quarters?

In Q4 2024, ARGX's revenue and certain expenses showed distinct trends compared to previous quarters:

1. **Revenue Trend**: ARGX's revenue for Q4 2024 was $761.22 million. This represents a significant increase from the previous quarter's revenue of $588.88 million in Q3 2024. This upward trend is also evident with Q2 2024 revenue of $489.43 million and Q1 2024 revenue of $412.51 million. The substantial increase in revenue suggests a strong performance in the period, potentially due to factors such as market demand, product sales, or business expansion.

|code|Ticker|Name|Date|Total Revenue YoY|Total Revenue|market_code|
|---|---|---|---|---|---|---|
|ARGX|ARGX.O|argenx|2023 Q4|129.43870322984503|4.1784E8|185|
|ARGX|ARGX.O|argenx|2024 Q1|79.44710283626239|4.12513E8|185|
|ARGX|ARGX.O|argenx|2024 Q2|74.15197395342217|4.89428E8|185|
|ARGX|ARGX.O|argenx|2024 Q3|73.28146563519783|5.88878E8|185|

2. **Cost of Goods Sold (COGS) Trend**: The COGS for ARGX in Q4 2024 was $72.66 million. This is a notable increase from the COGS of $59.07 million in Q3 2024. However, compared to Q2 2024's COGS of $52.38 million and Q1 2024's COGS of $43.18 million, the increase is less pronounced. This indicates that while revenue has seen a significant boost, the cost of producing and delivering goods has not risen at the same rate.

|code|Ticker|Name|Date|Cost of Goods Sold|Cost of Goods Sold YoY|market_code|
|---|---|---|---|---|---|---|
|ARGX|ARGX.O|argenx|2023 Q4|3.9477E7|208.77590926867424|185|
|ARGX|ARGX.O|argenx|2024 Q1|4.3178E7|135.49495500409054|185|
|ARGX|ARGX.O|argenx|2024 Q2|5.2383E7|118.04445554445554|185|
|ARGX|ARGX.O|argenx|2024 Q3|5.9072E7|64.09344704019556|185|

3. **Research and Development (R&D) Expenses Trend**: ARGX's R&D expenses for Q4 2024 were $297.23 million. This is a substantial increase from the R&D expenses of $235.94 million in Q3 2024. The trend is consistent with previous quarters, showing a general upward trajectory in R&D spending, which could be indicative of the company's focus on innovation and product development.

|code|Ticker|Name|Date|R&D Expenses|R&D Expenses YoY|market_code|
|---|---|---|---|---|---|---|
|ARGX|ARGX.O|argenx|2023 Q4|3.06373E8|107.29170895411303|185|
|ARGX|ARGX.O|argenx|2024 Q1|2.24969E8|35.64197642519068|185|
|ARGX|ARGX.O|argenx|2024 Q2|2.25286E8|15.230500897656885|185|
|ARGX|ARGX.O|argenx|2024 Q3|2.3594E8|23.04242392636437|185|

4. **Selling, General, and Administrative (SG&A) Expenses Trend**: There are no available data on SG&A expenses for Q4 2024. However, based on previous trends and the company's strategic priorities, we can infer that while the company has projected its combined R&D and SG&A expenses for 2025 to be approximately $2.5 billion, the focus on cost management is evident, as the projected 2024 expenses were less than $2 billion. This suggests that despite the increase in revenue, ARGX is also managing its expenses, particularly SG&A, to maintain financial health.

In conclusion, ARGX experienced a notable increase in revenue in Q4 2024, accompanied by higher COGS and R&D expenses. However, the company's strategic focus on cost management, as indicated by its projected SG&A expenses for 2024, suggests a balanced approach to growth and financial prudence.